AVIMOTIN

Details for Australian Trade Mark No. 1305950 (hide)

Owner MediGene AG

Convention EM 3 November 2008 007360043

Filing Date 28 April 2009

Classes

Class 5 Pharmaceutical and veterinary preparations for the prevention, treatment and/or diagnosis of diseases, in particular medicines, vaccines, serums and/or test kits for the prevention, treatment and/or diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neuronal tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basal cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and/or renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, lupus erythematosus and/or multiple sclerosis, neurodegenerative disorders, in particular Alzheimer's disease, Huntington's disease, multiple sclerosis, Parkinson's disease, schizophrenia, transmissible spongiform encephalopathy, bovine spongiform encephalopathy and/or Creutzfeldt-Jakob disease, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, Bechterew's disease, fibromyalgia and/or lupus erythematodes, allergic diseases, in particular allergies, allergic rhinitis, hay fever, asthma, atopic eczema and/or insect sting allergies, cardiovascular disorders, in particular hyperlipidaemia, coronary artery disorders, cardiac insufficiency, high blood pressure and/or obesity, skin diseases, in particular warts, genital warts, Bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and/or herpes, infectious diseases, in particular viral infections, bacterial infections, parasitic infections and/or fungal infections, and/or ophthalmic disorders, in particular age-dependent macular degeneration, glaucoma and/or retinoblastoma, in particular low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, T-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and/or plant extracts; in particular for oral, topical, intravenous and/or subcutaneous administration

Event Publications

16 July 2009 Application filed

30 July 2009 Application Accepted

26 November 2009 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1305951-HIROBRIZ

1305949